CTI BioPharma (CTIC) Tops Q1 EPS by 2c

CTI BioPharma (NASDAQ: CTIC) reported Q1 EPS of ($0.08), $0.02 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $10.5 million versus the consensus estimate of $8.73 million.

For earnings history and earnings-related data on CTI BioPharma (CTIC) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c